You must log in to view this page.

Kairos Pharma Ltd. – Plans of Reorganization, Merger, Acquisition or Similar

NYSE American: KAPA
Share price (7/2/26): $0.37
Market cap (7/2/26): $7.924 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Google Finance
SEC EDGAR

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.2

from S-1 23 pages Share Exchange Agreement

12/34/56

EX-2.1

from S-1 7 pages Agreement of Merger Between Kairos Pharma, LTD. and Actcell Biopharma, Inc. Filed Secretary of State State of California Nov 13 2019

12/34/56

EX-2.2

from DRS/A 25 pages Plan of reorganization, merger, acquisition or similar

12/34/56

EX-2.1

from DRS/A 8 pages Plan of reorganization, merger, acquisition or similar

12/34/56

Kairos Pharma Ltd. – Plans of Reorganization, Merger, Acquisition or Similar Watch

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

Kairos Pharma Ltd. – Plans of Reorganization, Merger, Acquisition or Similar